Key result
Prophylactic low-molecular-weight heparin administered from 7-8 weeks of gestation reduced the absolute risk of preeclampsia by 29.5% in pregnant women with Factor V Leiden mutation and severe APC resistance.
Why the study?
Does nadroparin calcium reduce placenta-mediated pregnancy complications in pregnant women with Factor V Leiden GA mutation and severe APC resistance?
RCT (n=141)
Block randomization
No
Does nadroparin calcium reduce placenta-mediated pregnancy complications in pregnant women with Factor V Leiden GA mutation and severe APC resistance?
Answers are grounded in this paper and cite their sources.
In pregnant women with Factor V Leiden GA mutation and severe APC resistance, prophylactic nadroparin calcium significantly reduced the risk of preeclampsia, fetal growth restriction, and induced preterm labor.
Not only a more pronounced increase in thrombin generation during pregnancy in FVL (1691) GA patients (compared to the normal genotype), but also a decrease in thrombin generation due to heparin prophylaxis were found out.
No takes yet. Share an insight, caveat, or question.
А. П. Момот (2018) conducted an RCT in Factor V Leiden (1691) GA mutation with severe APC resistance in pregnancy (n=141). Nadroparin calcium (Low-Molecular Weight Heparin) vs. No antenatal LMWH prophylaxis was evaluated on Preeclampsia (PE) (RR 0.23, 95% CI 0.1-0.51, p=0.001). Prophylactic low-molecular-weight heparin administered from 7-8 weeks of gestation reduced the absolute risk of preeclampsia by 29.5% in pregnant women with Factor V Leiden mutation and severe APC resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: